Skip to content

Startups

Virvio

Sectors
Biotechnology, Life Science

Graduated
Yes

Launched
12/20/2015

Description

Virvio is developing innovative solutions to treat infectious disease, specifically influenza virus. Virvio’s platform technology relies on strategic collaboration between computational design of novel protein therapeutics and their application in various models to treat disease, specifically influenza virus.

Team Members

Christopher Pirie

CEO

Merika Koday

Sr. Scientist

Gallery